{
  "success": true,
  "endpoint": "clean",
  "data": {
    "id": 92819342,
    "linkedin_source_id": "86011637",
    "name": "Bexorg, Inc.",
    "created_at": "2023-05-15",
    "last_updated": "2025-10-13",
    "websites_main": "https://bexorg.com",
    "websites_resolved": "https://bexorg.com/",
    "websites_main_original": "www.bexorg.com",
    "unique_website": true,
    "unique_domain": true,
    "expired_domain": false,
    "websites_linkedin": "https://www.linkedin.com/company/bexorg-inc",
    "websites_linkedin_canonical": "https://www.linkedin.com/company/bexorg-inc",
    "social_linkedin_urls": [
      "https://www.linkedin.com/company/bexorg-inc/"
    ],
    "websites_facebook": null,
    "social_facebook_urls": null,
    "websites_twitter": null,
    "social_twitter_urls": null,
    "social_x_urls": null,
    "social_instagram_urls": null,
    "social_youtube_urls": null,
    "social_github_urls": null,
    "social_reddit_urls": null,
    "social_discord_urls": null,
    "social_pinterest_urls": null,
    "social_tiktok_urls": null,
    "logo": "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",
    "enriched_b2b": 1,
    "ticker": null,
    "exchange": null,
    "description": "Bexorg is a privately held techbio company with the first-ever full tech stack platform to support CNS drug discovery and development in the human brain in a way that has not been possible before.\u202f\n\nOur proprietary whole-brain perfusion technology can be used to study brain connectivity, circuit function, and disease processes, with the aim to identify novel targets, biomarkers, and effectiveness of therapeutics for neurological disorders before going into the clinic. Our proprietary BrainEx platform generates high-fidelity human brain molecular datasets that drive our XO Digital application, a machine learning and AI-centered engine for drug discovery and development.\n\nIn collaboration with the NIH, Bexorg\u2019s founders have been at the forefront of bioethics in post-mortem human brain scientific research, and we have an independent board comprised of bioethics leaders to ensure our operations maintain the highest standards.\n\nBexorg is strategically partnering with leading neuroscience companies to integrate its platform into CNS clinical development programs, as well as advancing in-house neurodegeneration assets.",
    "enriched_summary": "minebright is a team of software engineers and mining professionals that work across industries to grow shareholder value by modernizing their client\u2019s systems and streamlining their business processes. They provide innovative software solutions tailored to the challenges of modern operations.",
    "metadata_title": "Decode the brain, build the future. | Bexorg",
    "metadata_description": "We are creating a world without brain disease.",
    "industry": "Biotechnology Research",
    "specialities": null,
    "enriched_keywords": [
      "mining professionals",
      "innovative software solutions",
      "software engineering",
      "mining industry",
      "data collection pipeline"
    ],
    "enriched_category": "Software Development",
    "type": "Privately Held",
    "founded": "2021",
    "size_range": "11-50 employees",
    "size_employees_count": 29,
    "size_employees_count_inferred": 23,
    "followers": 1650,
    "location_hq_raw_address": "New Haven, CT, United States",
    "location_hq_country": "United States",
    "location_hq_regions": [
      "Northern America",
      "Northern America",
      "AMER"
    ],
    "locations_full": [
      {
        "location_address": "-; New Haven, CT 06519, US",
        "is_primary": true
      }
    ],
    "updates": [
      {
        "followers": 1626,
        "date": "1mo",
        "description": "Alzheimer\u2019s and Parkinson\u2019s diseases demand human-relevant models. Bexorg\u2019s BrainEx sustains molecularly active whole human brains from patients with neurological diseases, enabling precise target validation, biomarker discovery, and therapeutic evaluation in authentic human disease conditions \u2014 before entering the clinic.\n\nLearn more at https://lnkd.in/ez5mp47d.",
        "reactions_count": 43,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1626,
        "date": "3mo",
        "description": "Today, we announced a multi-program research collaboration with Biohaven to help identify and advance next-generation therapies for CNS indications. As part of the collaboration, Bexorg\u2019s novel whole-brain discovery platform, BrainEx, will be used to generate biomarker and other data to support two preclinical programs at Biohaven, with the goal of informing IND-enabling studies and future clinical trials.\u00a0\n\u00a0\nWe are thrilled to team up with Biohaven to help advance its programs and potentially unlock a faster, more precise path to new CNS therapies.\u00a0\n\u00a0\nLearn more: https://bit.ly/45Oqz3G",
        "reactions_count": 105,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1626,
        "date": "4mo",
        "description": "We\u2019re honored to be featured in Endpoints News for our work unlocking the complexities of the human brain to accelerate breakthrough therapies for CNS disorders. The story spotlights BrainEx - our proprietary, whole-brain discovery platform and the only technology of its kind capable of identifying, de-risking, and advancing next-generation CNS treatments.\n\nWe\u2019re excited to continue pushing the boundaries of neuroscience and reimagining what\u2019s possible for patients. https://lnkd.in/e_vkzqKU",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1626,
        "date": "4mo",
        "description": "Bexorg will be at #BIO2025 in Boston, June 16-19. Connect with CEO & Co-founder Zvonimir Vrselja and CBO Brian Hotchkiss to learn how our BrainEx platform can derisk CNS pipelines. This first-of-its-kind whole human brain perfusion platform generates comprehensive OMICS data to help evaluate the effectiveness of therapeutics for CNS diseases before going into the clinic.\u00a0\u00a0\n\u00a0\nSchedule a meeting at https://bit.ly/3ZJurPG.",
        "reactions_count": 60,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1626,
        "date": "5mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 12,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1650,
        "date": "1mo",
        "description": "Alzheimer\u2019s and Parkinson\u2019s diseases demand human-relevant models. Bexorg\u2019s BrainEx sustains molecularly active whole human brains from patients with neurological diseases, enabling precise target validation, biomarker discovery, and therapeutic evaluation in authentic human disease conditions \u2014 before entering the clinic.\n\nLearn more at https://lnkd.in/ez5mp47d.",
        "reactions_count": 43,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1650,
        "date": "4mo",
        "description": "Today, we announced a multi-program research collaboration with Biohaven to help identify and advance next-generation therapies for CNS indications. As part of the collaboration, Bexorg\u2019s novel whole-brain discovery platform, BrainEx, will be used to generate biomarker and other data to support two preclinical programs at Biohaven, with the goal of informing IND-enabling studies and future clinical trials.\u00a0\n\u00a0\nWe are thrilled to team up with Biohaven to help advance its programs and potentially unlock a faster, more precise path to new CNS therapies.\u00a0\n\u00a0\nLearn more: https://bit.ly/45Oqz3G",
        "reactions_count": 105,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1650,
        "date": "4mo",
        "description": "We\u2019re honored to be featured in Endpoints News for our work unlocking the complexities of the human brain to accelerate breakthrough therapies for CNS disorders. The story spotlights BrainEx - our proprietary, whole-brain discovery platform and the only technology of its kind capable of identifying, de-risking, and advancing next-generation CNS treatments.\n\nWe\u2019re excited to continue pushing the boundaries of neuroscience and reimagining what\u2019s possible for patients. https://lnkd.in/e_vkzqKU",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1650,
        "date": "4mo",
        "description": "Bexorg will be at #BIO2025 in Boston, June 16-19. Connect with CEO & Co-founder Zvonimir Vrselja and CBO Brian Hotchkiss to learn how our BrainEx platform can derisk CNS pipelines. This first-of-its-kind whole human brain perfusion platform generates comprehensive OMICS data to help evaluate the effectiveness of therapeutics for CNS diseases before going into the clinic.\u00a0\u00a0\n\u00a0\nSchedule a meeting at https://bit.ly/3ZJurPG.",
        "reactions_count": 60,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1650,
        "date": "5mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 12,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1544,
        "date": "6d",
        "description": "Alzheimer\u2019s and Parkinson\u2019s diseases demand human-relevant models. Bexorg\u2019s BrainEx sustains molecularly active whole human brains from patients with neurological diseases, enabling precise target validation, biomarker discovery, and therapeutic evaluation in authentic human disease conditions \u2014 before entering the clinic.\n\nLearn more at https://lnkd.in/ez5mp47d.",
        "reactions_count": 35,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1544,
        "date": "2mo",
        "description": "Today, we announced a multi-program research collaboration with Biohaven to help identify and advance next-generation therapies for CNS indications. As part of the collaboration, Bexorg\u2019s novel whole-brain discovery platform, BrainEx, will be used to generate biomarker and other data to support two preclinical programs at Biohaven, with the goal of informing IND-enabling studies and future clinical trials.\u00a0\n\u00a0\nWe are thrilled to team up with Biohaven to help advance its programs and potentially unlock a faster, more precise path to new CNS therapies.\u00a0\n\u00a0\nLearn more: https://bit.ly/45Oqz3G",
        "reactions_count": 101,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1544,
        "date": "2mo",
        "description": "We\u2019re honored to be featured in Endpoints News for our work unlocking the complexities of the human brain to accelerate breakthrough therapies for CNS disorders. The story spotlights BrainEx - our proprietary, whole-brain discovery platform and the only technology of its kind capable of identifying, de-risking, and advancing next-generation CNS treatments.\n\nWe\u2019re excited to continue pushing the boundaries of neuroscience and reimagining what\u2019s possible for patients. https://lnkd.in/e_vkzqKU",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1544,
        "date": "2mo",
        "description": "Bexorg will be at #BIO2025 in Boston, June 16-19. Connect with CEO & Co-founder Zvonimir Vrselja and CBO Brian Hotchkiss to learn how our BrainEx platform can derisk CNS pipelines. This first-of-its-kind whole human brain perfusion platform generates comprehensive OMICS data to help evaluate the effectiveness of therapeutics for CNS diseases before going into the clinic.\u00a0\u00a0\n\u00a0\nSchedule a meeting at https://bit.ly/3ZJurPG.",
        "reactions_count": 60,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1544,
        "date": "4mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 12,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1531,
        "date": "2mo",
        "description": "Today, we announced a multi-program research collaboration with Biohaven to help identify and advance next-generation therapies for CNS indications. As part of the collaboration, Bexorg\u2019s novel whole-brain discovery platform, BrainEx, will be used to generate biomarker and other data to support two preclinical programs at Biohaven, with the goal of informing IND-enabling studies and future clinical trials.\u00a0\n\u00a0\nWe are thrilled to team up with Biohaven to help advance its programs and potentially unlock a faster, more precise path to new CNS therapies.\u00a0\n\u00a0\nLearn more: https://bit.ly/45Oqz3G",
        "reactions_count": 101,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1531,
        "date": "2mo",
        "description": "We\u2019re honored to be featured in Endpoints News for our work unlocking the complexities of the human brain to accelerate breakthrough therapies for CNS disorders. The story spotlights BrainEx - our proprietary, whole-brain discovery platform and the only technology of its kind capable of identifying, de-risking, and advancing next-generation CNS treatments.\n\nWe\u2019re excited to continue pushing the boundaries of neuroscience and reimagining what\u2019s possible for patients. https://lnkd.in/e_vkzqKU",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1531,
        "date": "2mo",
        "description": "Bexorg will be at #BIO2025 in Boston, June 16-19. Connect with CEO & Co-founder Zvonimir Vrselja and CBO Brian Hotchkiss to learn how our BrainEx platform can derisk CNS pipelines. This first-of-its-kind whole human brain perfusion platform generates comprehensive OMICS data to help evaluate the effectiveness of therapeutics for CNS diseases before going into the clinic.\u00a0\u00a0\n\u00a0\nSchedule a meeting at https://bit.ly/3ZJurPG.",
        "reactions_count": 60,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1531,
        "date": "3mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 12,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1507,
        "date": "2mo",
        "description": "Today, we announced a multi-program research collaboration with Biohaven to help identify and advance next-generation therapies for CNS indications. As part of the collaboration, Bexorg\u2019s novel whole-brain discovery platform, BrainEx, will be used to generate biomarker and other data to support two preclinical programs at Biohaven, with the goal of informing IND-enabling studies and future clinical trials.\u00a0\n\u00a0\nWe are thrilled to team up with Biohaven to help advance its programs and potentially unlock a faster, more precise path to new CNS therapies.\u00a0\n\u00a0\nLearn more: https://bit.ly/45Oqz3G",
        "reactions_count": 101,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1507,
        "date": "2mo",
        "description": "We\u2019re honored to be featured in Endpoints News for our work unlocking the complexities of the human brain to accelerate breakthrough therapies for CNS disorders. The story spotlights BrainEx - our proprietary, whole-brain discovery platform and the only technology of its kind capable of identifying, de-risking, and advancing next-generation CNS treatments.\n\nWe\u2019re excited to continue pushing the boundaries of neuroscience and reimagining what\u2019s possible for patients. https://lnkd.in/e_vkzqKU",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1507,
        "date": "2mo",
        "description": "Bexorg will be at #BIO2025 in Boston, June 16-19. Connect with CEO & Co-founder Zvonimir Vrselja and CBO Brian Hotchkiss to learn how our BrainEx platform can derisk CNS pipelines. This first-of-its-kind whole human brain perfusion platform generates comprehensive OMICS data to help evaluate the effectiveness of therapeutics for CNS diseases before going into the clinic.\u00a0\u00a0\n\u00a0\nSchedule a meeting at https://bit.ly/3ZJurPG.",
        "reactions_count": 60,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1507,
        "date": "3mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 12,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1453,
        "date": "1mo",
        "description": "Today, we announced a multi-program research collaboration with Biohaven to help identify and advance next-generation therapies for CNS indications. As part of the collaboration, Bexorg\u2019s novel whole-brain discovery platform, BrainEx, will be used to generate biomarker and other data to support two preclinical programs at Biohaven, with the goal of informing IND-enabling studies and future clinical trials.\u00a0\n\u00a0\nWe are thrilled to team up with Biohaven to help advance its programs and potentially unlock a faster, more precise path to new CNS therapies.\u00a0\n\u00a0\nLearn more: https://bit.ly/45Oqz3G",
        "reactions_count": 97,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1453,
        "date": "1mo",
        "description": "We\u2019re honored to be featured in Endpoints News for our work unlocking the complexities of the human brain to accelerate breakthrough therapies for CNS disorders. The story spotlights BrainEx - our proprietary, whole-brain discovery platform and the only technology of its kind capable of identifying, de-risking, and advancing next-generation CNS treatments.\n\nWe\u2019re excited to continue pushing the boundaries of neuroscience and reimagining what\u2019s possible for patients. https://lnkd.in/e_vkzqKU",
        "reactions_count": 40,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1453,
        "date": "1mo",
        "description": "Bexorg will be at #BIO2025 in Boston, June 16-19. Connect with CEO & Co-founder Zvonimir Vrselja and CBO Brian Hotchkiss to learn how our BrainEx platform can derisk CNS pipelines. This first-of-its-kind whole human brain perfusion platform generates comprehensive OMICS data to help evaluate the effectiveness of therapeutics for CNS diseases before going into the clinic.\u00a0\u00a0\n\u00a0\nSchedule a meeting at https://bit.ly/3ZJurPG.",
        "reactions_count": 60,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1453,
        "date": "2mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 11,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1420,
        "date": "3w",
        "description": "Today, we announced a multi-program research collaboration with Biohaven to help identify and advance next-generation therapies for CNS indications. As part of the collaboration, Bexorg\u2019s novel whole-brain discovery platform, BrainEx, will be used to generate biomarker and other data to support two preclinical programs at Biohaven, with the goal of informing IND-enabling studies and future clinical trials.\u00a0\n\u00a0\nWe are thrilled to team up with Biohaven to help advance its programs and potentially unlock a faster, more precise path to new CNS therapies.\u00a0\n\u00a0\nLearn more: https://bit.ly/45Oqz3G",
        "reactions_count": 94,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1420,
        "date": "3w",
        "description": "We\u2019re honored to be featured in Endpoints News for our work unlocking the complexities of the human brain to accelerate breakthrough therapies for CNS disorders. The story spotlights BrainEx - our proprietary, whole-brain discovery platform and the only technology of its kind capable of identifying, de-risking, and advancing next-generation CNS treatments.\n\nWe\u2019re excited to continue pushing the boundaries of neuroscience and reimagining what\u2019s possible for patients. https://lnkd.in/e_vkzqKU",
        "reactions_count": 36,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1420,
        "date": "3w",
        "description": "Bexorg will be at #BIO2025 in Boston, June 16-19. Connect with CEO & Co-founder Zvonimir Vrselja and CBO Brian Hotchkiss to learn how our BrainEx platform can derisk CNS pipelines. This first-of-its-kind whole human brain perfusion platform generates comprehensive OMICS data to help evaluate the effectiveness of therapeutics for CNS diseases before going into the clinic.\u00a0\u00a0\n\u00a0\nSchedule a meeting at https://bit.ly/3ZJurPG.",
        "reactions_count": 60,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1420,
        "date": "2mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 11,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1086,
        "date": "1mo",
        "description": "We\u2019re #hiring a new Veterinarian / Surgical Veterinary Technician in New Haven, Connecticut. Apply today or share this post with your network.",
        "reactions_count": 11,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 962,
        "date": "11mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 3,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "11mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1y",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 38,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 894,
        "date": "10mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "10mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "11mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "9mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "9mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "10mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "8mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "8mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "9mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "8mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 38,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "6mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "7mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "11mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 79,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "4mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "5mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "10mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 79,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "10mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 78,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "2mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "8mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 78,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "7mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 78,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "1mo",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 78,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2d",
        "description": "We are hiring! Join our team.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Lucija Barisic",
        "reshared_post_author_url": "https://www.linkedin.com/in/lucija-barisic-3b1aab10b",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Are you (or your friend/colleague) a software engineer passionate about biomedical research? Join us at bexorg.com, where you'll play a vital role in developing cutting-edge software systems. Let's decode the human brain together! \ud83e\udde0  \nhttps://lnkd.in/dn6VbsMf",
        "reshared_post_date": "2d",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2w",
        "description": "What if we could reanimate and keep alive human organs outside of the body for days at a time? Learn about a new era of #drugdiscovery with more physiological human disease models, #tissueengineering, and applications for #transplant #medicine in this session at #SynBioBeta2024: https://lnkd.in/gZHsCc2T",
        "reactions_count": 37,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "5mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 78,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 77,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 76,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 73,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4w",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 73,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1w",
        "description": "The human brain is home to a staggering 200 billion cells and 600 trillion connections, making it the most elaborate structure we know.\n\nBut the question is: \"Can we turn brainwaves into bytes?\"\n\nNo need to worry, because Zvonimir Vrselja  CEO of Bexorg, Inc.  answered that question at this year's The Geek Gathering\n\nPioneering Bexorg's innovative technology, he introduced a platform capable of revitalizing brain circulation and cellular functions after death, paving the path for groundbreaking explorations of complex brains.\n\nYour story has unquestionably sparked inspiration in many; thank you, Zvonimir! \ud83d\ude4c\ud83c\udffc",
        "reactions_count": 61,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      }
    ],
    "funding_rounds": null,
    "technologies": [
      {
        "technology": "typescript",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "pytorch",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "dash",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "harness",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "java",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "google cloud platform",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "mlops",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "sql",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "metabolomics",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "flask",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "propel",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "python",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "javascript",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "google cloud",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "react",
        "first_verified_at": "2025-04-08",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "scala",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "tensorflow",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-07"
      },
      {
        "technology": "avst",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-07"
      },
      {
        "technology": "matplotlib",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-07"
      },
      {
        "technology": "numpy",
        "first_verified_at": "2025-08-17",
        "last_verified_at": "2025-10-07"
      },
      {
        "technology": "box",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "impact",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-08-11"
      },
      {
        "technology": "well",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "microsoft",
        "first_verified_at": "2024-07-08",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "microsoft excel",
        "first_verified_at": "2025-02-18",
        "last_verified_at": "2025-06-09"
      },
      {
        "technology": "labview",
        "first_verified_at": "2024-09-16",
        "last_verified_at": "2025-03-17"
      },
      {
        "technology": "git",
        "first_verified_at": "2024-06-04",
        "last_verified_at": "2025-03-17"
      },
      {
        "technology": "linux",
        "first_verified_at": "2024-05-13",
        "last_verified_at": "2025-03-17"
      },
      {
        "technology": "matlab",
        "first_verified_at": "2024-09-16",
        "last_verified_at": "2025-03-17"
      },
      {
        "technology": "c",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2025-03-17"
      },
      {
        "technology": "google workspace",
        "first_verified_at": "2024-05-20",
        "last_verified_at": "2024-12-30"
      },
      {
        "technology": "solidworks",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-12-16"
      },
      {
        "technology": "debian",
        "first_verified_at": "2024-05-13",
        "last_verified_at": "2024-05-27"
      },
      {
        "technology": "ubuntu",
        "first_verified_at": "2024-05-13",
        "last_verified_at": "2024-05-27"
      },
      {
        "technology": "github",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-05-27"
      },
      {
        "technology": "prototype",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-04-04"
      },
      {
        "technology": "autocad",
        "first_verified_at": "2024-04-04",
        "last_verified_at": "2024-04-04"
      }
    ],
    "phone_numbers": [],
    "emails": [
      "bexorg@bexorg.com"
    ],
    "pricing_available": false,
    "free_trial_available": false,
    "demo_available": false,
    "is_downloadable": false,
    "mobile_apps_exist": false,
    "online_reviews_exist": false,
    "api_docs_exist": false
  },
  "status_code": 200
}